chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Decreased appetite, Fatigue, Mobility decreased, Pain
Clinical narrative: patient described soreness in arm and limited ability to lift it; patient described soreness in arm and limited ability to lift it; fever of 100.0 F; fatigue; body ache; no appetite; This is a spontaneous report from a contactable consumer.  A 37-year-old female (not pregnant) patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6201), via an unspecified route of administration on 10Mar2021 14:30 as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. Prior to vaccination and since the vaccination, the patient was not diagnosed with COVID-19.Previously on 17Feb2021 patient took the first dose of the vaccine (lot EL9269) at the age of 37 years for covid-19 immunisation. On  10Mar2021 the patient experienced soreness in arm and limited ability to lift it, fever of 100.0 F,fatigue, body ache and no appetite. It was unknown if treatment was given. Outcome of the events was recovering.No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: patient described soreness in arm and limited ability to lift it; patient described soreness in arm and limited ability to lift it; fever of 100.0 F; fatigue; body ache; no appetite; This is a spontaneous report from a contactable consumer.  A 37-year-old female (not pregnant) patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6201), via an unspecified route of administration on 10Mar2021 14:30 as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. Prior to vaccination and since the vaccination, the patient was not diagnosed with COVID-19.Previously on 17Feb2021 patient took the first dose of the vaccine (lot EL9269) at the age of 37 years for covid-19 immunisation. On  10Mar2021 the patient experienced soreness in arm and limited ability to lift it, fever of 100.0 F,fatigue, body ache and no appetite. It was unknown if treatment was given. Outcome of the events was recovering.No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dizziness, Malaise, Myalgia
Clinical narrative: not feeling good; pulsating at the injection site/arm; when will his taste buds will be back or the smell.; when will his taste buds will be back or the smell.; fever; dizziness; muscle aches; nausea; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, at 1st dose, single dose for COVID-19 immunization. Medical history included COVID in Oct2020. Concomitant medications were not reported. The patient had COVID back in the Oct2020 and after taking first dose of BNT162b2 he was experiencing all the symptoms which he experienced with the COVID-19: fever, dizziness, muscle aches, nausea, not feeling good, pulsating at the injection site/arm. He wanted to know about if he was contagious and when would his taste buds would be back or the smell. The patient had not recovered from when will his taste buds will be back or the smell, the outcome of the other events was unknown.   Follow-up attempts are completed. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site reaction
Clinical narrative: not feeling good; pulsating at the injection site/arm; when will his taste buds will be back or the smell.; when will his taste buds will be back or the smell.; fever; dizziness; muscle aches; nausea; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, at 1st dose, single dose for COVID-19 immunization. Medical history included COVID in Oct2020. Concomitant medications were not reported. The patient had COVID back in the Oct2020 and after taking first dose of BNT162b2 he was experiencing all the symptoms which he experienced with the COVID-19: fever, dizziness, muscle aches, nausea, not feeling good, pulsating at the injection site/arm. He wanted to know about if he was contagious and when would his taste buds would be back or the smell. The patient had not recovered from when will his taste buds will be back or the smell, the outcome of the other events was unknown.   Follow-up attempts are completed. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Miliaria, Rash pruritic
Clinical narrative: prickly heat rash; itchy rash; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on unspecified date in Mar2021 as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient asked if she should receive the 2nd dose if she had an itchy rash all over her body 8 days after the 1st dose on 11Mar2021. She had an extremely itchy rash all over her body. It came on suddenly. It occurred 8 days after the 1st dose. It looked exactly like a prickly heat rash. She called her doctor, but he said they have nothing to do with the vaccine declined to offer any management. She took diphenhydramine (BENADRYL) and used a DOMEBORO compress. The side effect did go away. This started the day before the present report in the afternoon (11Mar2021). It worsened throughout the night. The case was reported as non-serious. The outcome of the events was resolved.  No follow-up attempts are needed; information about lot/batch number cannot been obtained.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache
Clinical narrative: she reports a headache only on her right side of her head; weakness; This is a spontaneous report from a contactable consumer (patient).   A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on 09Mar2021 (at 73 years) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced weakness on 09Mar2021 and next night (10Mar2021) she reported a headache only on her right side of her head. She wanted to know if she can still have the second dose of the vaccine as scheduled on 29Mar2021, the day before at night time a headache in the right side of head. The final outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Muscle fatigue, Night sweats, Somnolence, Vaccination site pain
Clinical narrative: sleeping more than used to/11-12 hours of sleep; lot more fatigue than usual; night sweats; muscle soreness at injection site; muscle fatigue in various spots of the body; This is a spontaneous report from a contactable consumer (patient).   A 77-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included myalgia, urinary tract infection. The patient's concomitant medications were not reported. The patient experienced muscle soreness at injection site on 06Mar2021, muscle fatigue in various spots of the body on 06Mar2021, sleeping more than used to/11-12 hours of sleep on an unspecified date, lot more fatigue than usual on an unspecified date, night sweats on an unspecified date. The events outcome was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Flushing, Hypersensitivity
Clinical narrative: Lot of allergy; Itching on her eyes; Face was flushed, it looked red; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 09Mar2021 (batch/lot number was not reported) as 1st dose, single dose for COVID-19 immunization. Medical history included COVID from Apr2020 (had COVID before the vaccine), high blood pressure, cholesterol (abnormal), diabetes, and circulatory problems. The patient's concomitant medications were not reported. The patient received the first dose of BNT162B2 in the morning of 09Mar2021. She was monitored for half an hour and she was fine. An hour later, the patient started feeling itching on her eyes, and later that evening, her face was flushed, it looked red like she had "a lot of allergy". The patient went to the hospital and she received 3 medicines for 4 days. The patient still had some flush. The doctor told the patient she cannot get the second dose. She had COVID in April before the vaccine. The patient wanted to know if she had antibodies left. Besides, she has high blood pressure, cholesterol, diabetes, and circulatory problems. The patient needed to travel and therefore needs the 2 doses, but if she can't get the second, she wondered what will be written on her vaccination card. The second dose was scheduled for 30Mar2021. The outcome of the event flushed face was not recovered while the outcome of the remaining events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: experienced some itching at the injection site in left arm; This is a spontaneous report from a contactable consumer (patient).  A 81-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included memory impairment ongoing from an unknown date. The patient's concomitant medications were not reported.  The patient experienced some itching at the injection site in left arm on an unspecified date. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Pain in extremity, Pruritus, Rhinorrhoea, Skin discolouration
Clinical narrative: runny & itchy nose; runny & itchy nose; bad joint inflammation; pain in her great toe; toe has appeared to be dark pink in color with improvement noted; This is a spontaneous report from a contactable consumer reporting for mother in low  An 87 year old female patient received first dose  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 06Mar2021 at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 09Mar2021 the patient experienced runny & itchy nose, bad joint inflammation, pain in her great toe. It was also reported that toe has appeared to be dark pink in color with improvement noted. At the time of the reporting events outcome was unknown.    No follow-up attempts are possible, information about batch number cannot be obtained
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold
Clinical narrative: She felt 'weird'.; she noticed a cooling effect at the bottom of her ribcage; This is a spontaneous report received from a contactable female consumer (Patient) and a contactable consumer (husband).   A 78-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 08Mar2021 15:50 (Batch/Lot Number: EN6206) as  single dose for covid-19 immunisation.   Medical history included hypothyroidism from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for hypothyroidism from an unspecified start date and ongoing and multivitamins.  The patient experienced she felt 'weird'. (feeling abnormal) (non-serious) on an unspecified date with outcome of unknown, she noticed a cooling effect at the bottom of her ribcage (feeling cold) (non-serious) on 09Mar2021 with outcome of not recovered.    Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle tightness
Clinical narrative: neck tightness; This is a spontaneous report from a contactable Pharmacist (patient) via Medical  Information Team. A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on 13Feb2021 as first dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date the patient experienced neck tightness, denied any issues with breathing. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021283574 Same pt/drug, different dose
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Throat tightness
Clinical narrative: neck tightness; This is a spontaneous report from a contactable Pharmacist (patient) via Medical  Information Team. A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on 13Feb2021 as first dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date the patient experienced neck tightness, denied any issues with breathing. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021283574 Same pt/drug, different dose
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extreme fatigue, moderate fatigue, mild fatigue; This spontaneous report from a contactable consumer (patient). A non-pregnant 50-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), dose 1, administered on left arm on 08Mar2021 (Lot Number: EN6202) as 1st dose, single dose (at the age of 50 years old) for COVID-19 immunization. The patient's medical history included asthma. The patient's concomitant medications were not reported. On 08Mar2021 at 16:30 and 09Mar2021, the patient experienced extreme fatigue. On 10Mar2021, the patient experienced moderate fatigue. On 11Mar2021, the patient experienced mild fatigue. The patient received no treatment for the events. The patient also reported of no known allergies. The outcome of the events was recovering.     No follow up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site pain
Clinical narrative: sore arm at injection site; lightheadedness; This is a spontaneous report received . A contactable other healthcare professional (patient) reported a 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on right arm on 09Mar2021 (at the age of 72 years old) (Batch/Lot number: en6206) as 1st dose, single dose for COVID-19 immunisation. Patient's medical history included hay fever and food allergy to egg. Concomitant medications were not reported. The patient previously received carbamazepine (TEGRETOL), fluvoxamine maleate (RELAFIN) and clonixin lysinate (SKELAXIN) for unspecified indications and experienced allergies. On 09Mar2021 19:30, the patient experienced sore arm at injection site with a few episodes of lightheadedness. The patient received no treatment for the events. The patient was able to recover from the events on 12Mar2021 (reported as lasted for 3 days).  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Moderate headache; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 63-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), dose 1, administered on left arm on 12Mar2021 at 14:15 (Lot number: not available at the time of report completion) as 1st dose, single dose (at the age of 63 years old) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has known allergies on prednisone. On 12Mar2021 at 15:15 the patient experienced moderate headache for 30 minutes onset after vaccination which lasted about 3 to 3.5 hours. It was resolved after hydrating with two bottles of water and food at dinner time. The patient received no treatment for the event. The outcome of the event was recovered on 12Mar2021 19:15.  No follow-up attempts are possible; information on lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Feeling abnormal, Pain, Pyrexia
Clinical narrative: strong pain in his abdomen and right side of his body; strong pain in his abdomen and right side of his body; took his body temperature and it was at 99.14 Farenheit (F); He checked his temperature which was recorded as 101.66 F; he recorded his temperature to be at 101.67 F; patient was feeling bad; he felt bad all Friday and was in bed for the whole day; This is a spontaneous report received. A contactable consumer (patient) reported a non-pregnant 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unknown route of administration, administered on left arm on 02Mar2021 16:00 (Batch/Lot number: EL9262) as 1st dose, single dose (at the age of 59 years old) for COVID-19 immunisation. Patient's medical history included Barrett's esophagitis (Barret esophagus) on an unspecified date and penicillin allergy. Concomitant medications included pantoprazole via an unspecified route of administration from an unspecified date at 40mg daily for an unspecified indication. On 11Mar2021 01:30, the patient reported waking up in the middle of the night with a strong pain in his abdomen and right side of his body. He thought it was because of his gallbladder and claimed that he had the vaccine last week so he wasn't sure. The next morning (yesterday (reported)), the patient was feeling bad so he took his body temperature and it was at 99.14 Fahrenheit (F). He stated that he felt bad all Friday and was in bed for the whole day. He checked his temperature which was recorded as 101.66 F (pyrexia) and took one ibuprofen (ADVIL LIQUID GEL) at 07:15. At 09:20, he recorded his temperature to be at 101.67 F. The patient was asking for advice. The patient did not receive treatment for the other events other than pyrexia. The outcome of the reported events were not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Vomiting; diarrhoea; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 61-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), dose 1, via an unspecified route of administration, administered on right arm on 10Mar2021 (Lot number: EN6208) as 1st dose, single dose for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medication included cetirizine hydrochloride (ZYRTEC), escitalopram oxalate (LEXAPRO Strength: 5mg), and trazadone 50mg. The patient's known allergies included cefalexin monohydrate (KEFLEX), minocycline, and NSAIDS. On 12Mar2021 at 23:45, the patient experienced vomiting and diarrhea. The patient received no treatment for the events. The outcome of the events was recovering.    No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rashes; This is a spontaneous report received. A contactable consumer (patient) reported a 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unknown route of administration, administered on left arm on 18Feb2021 17:00 (Batch/Lot number: EN6201) as 1st dose, single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. The patient has not had COVID before vaccination nor tested after vaccination. On 20Feb2021, the patient experienced rashes at various parts of his body. He claimed that the rashes tend to become darker and start out very rough like medium sandpaper. The patient reported that he had not known of any allergies and it was his first reaction in over 30 years. The patient did not receive treatment for the reported event. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Muscular weakness, Myalgia
Clinical narrative: pain in my hip and when she just lay down or rest also have the body; muscle pain; Joint pain/wrist will have all kind of pain/pain in my hip; Muscle weakness; headache; tiredness; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Mar2021 (Batch/Lot Number: EN6202) as 1st dose, single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had mild symptoms the next day (04Mar2021) which she was really not concerned about, just tiredness for about 6 hours and some headache. On day 7 after first dose (10Mar2021), she began to experience joint pain and muscle weakness; the patient was still experiencing the symptoms. It was not terrible pain but when she try to open a door and her wrist will have all kind of pain, pain in my hip and when she just lay down or rest also have the body and she also didn't have the joint pain in general. The first time of experience of muscle pain. The day when she reported makes day 10 do the symptoms listed. The patient saw that the symptom should resolve in 24 to 48 hours, so she was surprised after 7 days about having kind of like a joint pain. The outcome of tiredness was recovered in Mar2021, not recovered for joint pain and muscle weakness and unknown for the other events.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: pain in my hip and when she just lay down or rest also have the body; muscle pain; Joint pain/wrist will have all kind of pain/pain in my hip; Muscle weakness; headache; tiredness; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 03Mar2021 (Batch/Lot Number: EN6202) as 1st dose, single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had mild symptoms the next day (04Mar2021) which she was really not concerned about, just tiredness for about 6 hours and some headache. On day 7 after first dose (10Mar2021), she began to experience joint pain and muscle weakness; the patient was still experiencing the symptoms. It was not terrible pain but when she try to open a door and her wrist will have all kind of pain, pain in my hip and when she just lay down or rest also have the body and she also didn't have the joint pain in general. The first time of experience of muscle pain. The day when she reported makes day 10 do the symptoms listed. The patient saw that the symptom should resolve in 24 to 48 hours, so she was surprised after 7 days about having kind of like a joint pain. The outcome of tiredness was recovered in Mar2021, not recovered for joint pain and muscle weakness and unknown for the other events.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Malaise, Pain
Clinical narrative: General malaise; Fatigue; Dizziness; bodies aches and pains; occasional diarrhea; This is a spontaneous report from a contactable consumer (patient) and another consumer received from a Pfizer-sponsored program. A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 03Mar2021 07:15 (at the age of 54 years old), as first dose, single dose for COVID-19 immunization. Medical history included asthma and IPT. The patient had no known allergies. Concomitant medication included ongoing acetylsalicylic acid (ASPIRIN). On 04Mar2021, 05:00 AM, the patient experienced general malaise and fatigue at times increasing in waves mixed with dizziness over the past 10 days, to the point where rest was required. First 3 days, bodies aches and pains, occasional diarrhea. The patient had no COVID prior vaccination, and was not COVID tested post vaccination. The patient informed that he was scheduled to have his second dose on 02Apr2021. He mentioned he is currently taking low dose Aspirin 80 mg and wanted to know if he should stop taking it before the vaccine. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Fatigue, Headache, Pain
Clinical narrative: Headache; body aches; tired; loss of taste; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 09Mar2021 14:30 (Batch/Lot number was not reported) (at the age of 53 years-old) as 2nd dose, single dose for covid-19 immunisation.  Medical history included thyroid, migraine, allergy, acid reflux. However, the patient also reported that her other medical history was "none". The patient was not pregnant. The patient did not have Covid prior to vaccination. The patient had no known allergies. Concomitant medications included medications for thyroid, migraine, allergy, acid reflux and an inhaler. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm on 16Feb2021 at 02:30 PM (at the age of 53-years-old) for Covid-19 immunisation. The patient did not receive other vaccines in four weeks. The patient experienced headache, body aches, tired, loss of taste/lost sense of taste. All started 20 hrs after on 10Mar2021 at 10:30 AM. Loss of taste was still here 4 days later.  No treatment was received for the events. The patient was not tested for Covid post vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: Vertigo type feelings; Woosey and a little nauseous; This is a spontaneous report received. A contactable consumer (patient) reported 80-year-old patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unknown route of administration, administered on left arm on 10Mar2021 10:00 (at the age of 80 years old) (Batch/Lot Number: not reported) as 1st dose, single dose, for COVID-19 immunisation. Patient's medical history included benign prostatic hyperplasia (BPH)  on an unspecified date and penicillin allergy. Concomitant medications were not reported. The patient has not had COVID before vaccination nor tested after vaccination. On 12Mar2021 06:00, the patient experienced vertigo type feelings. The patient felt woosey and a little nauseous. The patient did not receive treatment for the reported events. The outcome of the reported events were recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took 1st dose of BNT162B2 on an unspecified date for COVID-19 immunisation. The patient (reporter's mother's cardiologist) had a reaction to his second Pfizer shot and on an unspecified date, experienced flu like symptoms for 36 hours. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: little bit of a swollen arm; This is a spontaneous report from a Pfizer Sponsored program . A contactable consumer (patient herself) reported that a 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 18Feb2021, as first dose, single dose for COVID-19 immunisation. Medical history included ongoing allergy. Concomitant medication included fexofenadine hydrochloride (ALLEGRA) taken for allergy from an unspecified start date and ongoing. The patient experienced little bit of a swollen arm on an unspecified date. Patient stated that she received her first dose of the Pfizer COVID-19 vaccine on 18Feb2021 and experienced a little bit of a swollen arm but it was no big deal. Patient would like any information regarding the use of antihistamines specifically ALLEGRA with the Pfizer COVID-19 vaccine. She stated that she has allergies and this is a medication that she takes on a daily basis. The outcome of event was unknown.  No follow-up attempts are needed; information on lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: This is a spontaneous report from a contactable other health care professional (patient). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported),via an unspecified route of administration, administered on left leg on 31Jan2021 at 13:00 (reported as 01:00 PM) (at the age of 61 years old) as first dose, single for COVID-19 immunization. The facility where the vaccine was administered was reported to be "other". The patient medical history was not reported. Patient has known allergies with Bupivacaine on an unspecified date. The patient was not pregnant at the time of vaccination and did not receive any other vaccines in 4 weeks. Prior to vaccine the patient was not diagnosed with COVID-19. Concomitant medication included paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported.  The patient experienced ringing in ear on 21Feb2021 at 04:00 (reported as 04:00 AM). No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of event was not recovered. The patient received the second dose of BNT162B2 (lot number: not reported) via an unspecified route of administration, administered in left arm on 21Feb2021 at 01:15PM, at the age of 61 years old as second dose, single for COVID-19 immunization. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Headache, Pain, Pain in extremity
Clinical narrative: Sore arm for 36 hours; Dull ache; a dull headache above my left eye; a dull headache, radiating down the left side of my face radiating down the left side of my face; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6207; Expiration date were not reported), via unspecified route of administration in the left arm on 11Mar2021 10:00 AM (at the age of 64-years-old) as first dose, single dose for COVID-19 immunisation at a hospital. Medical history included chronic kidney stones, Sulfa allergy, both from an unknown date and unknown if ongoing; and shingles (had a 6 week bout of it, 24/7 excruciating headache, above her left eye and radiating down the left side of my face) from 2013 to an unknown date. Concomitant medications included lisinopril, amlodipine, pantoprazole and cetirizine; all taken for an unspecified indication, start and stop dates were not reported. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 12Mar2021 10:00 PM, the patient experienced sore arm for 36 hours, dull ache and, a dull headache above my left eye and radiating down the left side of my face (reported to be at appx hour 36). The patient was not prone to headaches generally and reported that the headache that she was experiencing now was in the same place when she had shingles. No treatment was taken for the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity, Tendon disorder
Clinical narrative: tendons in both hands kept making snapping/cracking sounds; severe pain in both thumbs, to the point I could not hold anything; severe pain in both thumbs, to the point I could not hold anything; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6205, Expiration date was not reported), via an unspecified route of administration (administered on the right arm) on an unspecified date in Mar2021 (at the age of 70-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included migraines, sulfa allergy, shellfish allergy and strawberries allergy all from an unknown date. Concomitant medications included tamsulosin, trimethoprim, bromelains, flunisolide (TURM) and MygranX all taken for an unspecified indication, start and stop date were not reported. The patient previously took DEMEROL and experienced allergy. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. On 08Mar2021, the patient experienced tendons in both hands kept making snapping/cracking sounds and severe pain in both thumbs, to the point i could not hold anything. It was reported that for 6 days the tendons in both hands kept making snapping/cracking sounds like if you crack your fingers and at times the patient had severe pain in both thumbs, to the point she could not hold anything. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.   No follow-up attempts are possible. No further information expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint pain all over my entire body; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6204, expiration date not reported), via an unspecified route of administration, administered in the left arm on 09Mar2021 11:00 (at the age of 50-years-old), as second dose, single dose for COVID-19 immunisation. Medical history included HIV and Diabetes Type II. Concomitant medications included emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide fumarate (ODEFSEY); pioglitazone; and testosterone (ANDROGEL) all taken for an unspecified indication, all start and stop dates were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9261, expiration date not reported), via an unspecified route of administration, administered in the left arm on 16Feb2021 11:00 (at the age of 50-years-old), as first dose, single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced joint pain all over my entire body on 13Mar2021, four days after the 2nd dose. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint space narrowing, Joint swelling, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: right index finger became very stiff and I was unable to straighten it; knuckle of my right index finger became swollen and tender; knuckle of my right finger became tender; joint space narrowing; My finger continues to be sore; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN 6198; Expiration date were not reported), intramuscularly in the left arm on 27Feb2021 12:15 PM (at the age of 38-years-old) as first dose, single dose for COVID-19 immunisation at a hospital. Medical history included autonomic dysfunction, allergy to wasp, anaphylaxis (from allergy to wasp); all from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT) and fludrocortisone; both taken for an unspecified indication, start and stop dates were not reported. The patient previously took cefalexin (KEFLEX) and ciprofloxacin (CIPRO) and experienced drug allergy. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 04Mar2021 (reported as five days after receiving the vaccine), the patient experienced her right index finger became very stiff and was unable to straighten it, knuckle of her right index finger became swollen and tender, joint space narrowing (from the x-ray result) and her finger continues to be sore. The adverse events resulted in an urgent care visit. The patient underwent lab test and procedure which included X-ray:  normal except for some joint space narrowing on 04Mar2021. The patient was referred to ortho which has yet to be scheduled. Therapeutic measure with one dose of prednisone 5mg, which was prescribed by the patient's cardiologist, was taken as a result of the events. The outcome of the event finger continues to be sore was not recovered where it continues to be sore; outcome of the other events was recovering. It was reported that the patient was able to straighten her finger again and slightly stiff but is improving.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: right index finger became very stiff and I was unable to straighten it; knuckle of my right index finger became swollen and tender; knuckle of my right finger became tender; joint space narrowing; My finger continues to be sore; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN 6198; Expiration date were not reported), intramuscularly in the left arm on 27Feb2021 12:15 PM (at the age of 38-years-old) as first dose, single dose for COVID-19 immunisation at a hospital. Medical history included autonomic dysfunction, allergy to wasp, anaphylaxis (from allergy to wasp); all from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT) and fludrocortisone; both taken for an unspecified indication, start and stop dates were not reported. The patient previously took cefalexin (KEFLEX) and ciprofloxacin (CIPRO) and experienced drug allergy. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 04Mar2021 (reported as five days after receiving the vaccine), the patient experienced her right index finger became very stiff and was unable to straighten it, knuckle of her right index finger became swollen and tender, joint space narrowing (from the x-ray result) and her finger continues to be sore. The adverse events resulted in an urgent care visit. The patient underwent lab test and procedure which included X-ray:  normal except for some joint space narrowing on 04Mar2021. The patient was referred to ortho which has yet to be scheduled. Therapeutic measure with one dose of prednisone 5mg, which was prescribed by the patient's cardiologist, was taken as a result of the events. The outcome of the event finger continues to be sore was not recovered where it continues to be sore; outcome of the other events was recovering. It was reported that the patient was able to straighten her finger again and slightly stiff but is improving.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vaccination site pruritus
Clinical narrative: little soreness in the arm; feels slightly nauseous; Itching at the injection site minutes after the injection; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. It was unknown if other vaccine was administered in four weeks. On 12Mar2021, the patient experienced itching at the injection site minutes after the injection, no other itches. The patient also experienced a little soreness in the arm today (a day after injection, 13Mar2021) and she also feels slightly nauseous but still fully able to do housework and to exercise. It was unknown if treatment was given; if patient had COVID prior vaccination and if patient was tested for COVID post vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site rash
Clinical narrative: Large raised itchy 4" long red patch at injection site; Large raised itchy 4" long red patch at injection site; This is a spontaneous report from a contactable consumer (patient). A 71-year-old non-pregnant female patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6202, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 08Mar2021 10:30 (at the age of 71-years-old) as 2nd dose, single dose for COVID-19 immunisation. Medical history included asthma and allergy to sulfa products, Advair discus, Augmentin, and Premarin cream all from an unknown date. The patient's concomitant medications included unspecified asthma medications. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EL9266, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 15Feb2021 10:30  for COVID-19 immunisation. The patient experienced large raised itchy 4" long red patch at injection site on 08Mar2021 17:00. No treatment was received for the event. Since the vaccination the patient has not been tested for COVID-19.  The outcome of the event was recovering.   No follow-up attempts are possible. No further information expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Sensation of foreign body
Clinical narrative: slight difficulty swallowing; feeling of something stuck in my throat; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration, administered in the left arm on 12Mar2021 11:45 (at the age of 57-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced slight difficulty swallowing and feeling of something stuck in my throat on 13Mar2021 00:30. Patient did not seek consult to physician or urgent care. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Swollen lymph nodes at jaws; rash on stomach; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration in the right arm on 12Mar2021 11:00 AM (at the age of 62-years-old) as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 13Mar2021 13:00 PM, the patient experienced swollen lymph nodes at jaws and rash on stomach. It was unknown if treatment was received for the events. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The outcome of the events was not recovered.   No follow-up attempts are possible; information about the batch/lot number cannot be obtained. No further information is expected.